261. Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study.
作者: Maria Jose Villar.;Stefano Di Donato.;Maria Francisca Bozan.;Joanne Manning.;Melissa Mandzuk.;Elizabeth Wragg.;Muditha Samaranayaka.;Andrea Murray.;Ariane L Herrick.;Graham Dinsdale.;Michael Hughes.
来源: Rheumatology (Oxford). 2025年64卷11期5883-5891页
Cardiac involvement is common in SSc and is associated with high mortality, yet is challenging to detect. Our aim was to investigate relationships between cardiac involvement, as assessed by ECG and transthoracic echocardiography (TTE), and thermographic abnormalities.
262. Prevalence of autoimmune diseases is strongly associated with average annual temperatures: systematic review and linear regression analysis.
作者: Konstantinos Voskarides.;Sofia Philippou.;Mariam Hamam.;Konstantinos Parperis.
来源: BMC Rheumatol. 2025年9卷1期86页
The incidence of autoimmune diseases in cold environments has been a topic of interest due to the observed geographical patterns and potential environmental influences on disease development. We aimed to investigate the prevalence of five main autoimmune diseases in 201 countries according to average annual temperatures.
263. Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation.
作者: Francesca Romana Di Ciommo.;Livia Casciola-Rosen.;Ali Yagiz Ayla.;Ashish Balar.;Ami A Shah.;Michael Hughes.;Walter Morales.;Mark Pimentel.;Brittany L Adler.;Zsuzanna H McMahan.
来源: Rheumatology (Oxford). 2025年64卷12期6349-6353页
Anti-cytolethal distending toxin (CDT) antibodies may serve as biomarkers for post-infectious autoimmunity and aid clinical risk stratification. We aimed to determine the prevalence of anti-CDT antibodies in a large, well-characterized cohort of systemic sclerosis (SSc) patients and examine associations with gastrointestinal (GI) and extraintestinal clinical features and SSc-related antibodies.
264. Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors.
作者: Sebastian Hüper.;Florian Eisele.;Johannes Duell.;Marc Schmalzing.;Lea Nagler.;Patrick Pascal Strunz.;Matthias Froehlich.;Jan Portegys.;Michael Gernert.
来源: BMC Rheumatol. 2025年9卷1期84页
Janus kinase inhibitors (JAKi) represent a well-established therapeutic option for the treatment of autoimmune diseases. However, there is a paucity of evidence regarding their impact on de novo immune responses to vaccinations. T cells may confer long-lasting immunity and cross-recognise evolving epitopes of new viral variants, as evidenced by the SARS-CoV-2 vaccination. Consequently, we investigated the de novo T-cell response to SARS-CoV-2 vaccination in patients with rheumatic diseases undergoing treatment with JAK inhibitors.
265. Low-density lipoprotein cholesterol mediates the causal association between systemic lupus erythematosus and asthma: a mediation mendelian randomization study.
It is well-documented that systemic lupus erythematosus (SLE) is associated with asthma. However, the causal relationship between SLE and asthma, and the potential mediator need to be explained. This study aims to confirm the cause-and-effect relationship between SLE and asthma, and evaluate the mediation effect of lipid in European ancestry.
266. Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors.
作者: Martyna Hempel.;Erik Klapproth.;Annika Krause.;Christoph Becker-Pauly.;Sebastian Zeissig.;Babett Heschel.;Nadine Weser.;Julia Fantana.;Nicolai Leuchten.;Stefan Rose-John.;Ali El-Armouche.;Adelheid Korb-Pap.;Martin Aringer.
来源: Rheumatology (Oxford). 2025年64卷11期5793-5802页
To fully understand why C-reactive protein (CRP) is usually only mildly elevated in active systemic lupus erythematosus (SLE), although interleukin-6 (IL-6) is increased, but is high in SLE patients with bacterial infections.
267. Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome.
作者: Syed B Ali.;Alexander Troelnikov.;Bridie Amour.;Lauren Hender.;Dimitra Beroukas.;Tim Chataway.;Vidya Limaye.;Tom P Gordon.;Jing Jing Wang.
来源: Rheumatology (Oxford). 2025年64卷12期6398-6403页
Anti-PL12 autoantibodies are targeted against alanyl-tRNA synthetase, a cytosolic enzyme which plays a vital role in protein synthesis. Clinically, such antibodies are strongly associated with interstitial lung disease and confer a poor prognosis. To better understand their molecular composition, anti-PL12 immunoglobulin variable region subfamily expression and their mutational signatures were analysed by mass spectrometry (MS)-based proteomics to provide insights into personalized molecular diagnosis.
269. Minimal important differences of measurement instruments used in rheumatoid arthritis: a scoping review.
作者: Sally Yaacoub.;Anas El Zouhbi.;Michella Abi Zeid Daou.;Vicky Nahra.;Abir Mokbel.;Layal Hneiny.;Liana Fraenkel.;Bradley C Johnston.;Elie A Akl.
来源: BMC Rheumatol. 2025年9卷1期83页
Many outcomes relevant to rheumatoid arthritis are measured as continuous variables. Judging whether the results of those measurements are clinically significant requires determining the minimal important difference (MID) estimate. Therefore, valid MID estimate(s) are essential for the purposes of clinical decision-making and developing clinical recommendations. Our objective is to present the MID estimates for instruments used to measure outcomes in rheumatoid arthritis studies.
270. Effects of high-intensity interval training on patients with inflammatory arthritis: a systematic review.
作者: Christopher Sutherland.;Tadesse Gebrye.;Adekola Ademoyegun.;Francis Fatoye.;Chidozie Mbada.
来源: BMC Rheumatol. 2025年9卷1期82页
Despite reports of clinical benefits, concerns persist about the stress associated with high-intensity interval training (HIIT) in patients with inflammatory arthritis (IA). This review aimed to assess the effects of HIIT on disease activity, immune function, symptoms, cardiorespiratory fitness (CRF), and overall health-related quality of life (HRQoL) in patients with IA.
271. Frequency, diagnosis, and management of polymyalgia rheumatica in Germany-database analysis of medical insurance data.
作者: Wolfgang A Schmidt.;Marco Alibone.;Paul Ludwig.;Dominik Obermüller.;Franziska Karl.;Stephanie Terner.;Nils Venhoff.
来源: Rheumatology (Oxford). 2025年64卷11期5818-5825页
Epidemiological data on polymyalgia rheumatica (PMR) in Germany is limited. Current national prevalence estimates are low by international standards. This study aimed to gain up-to-date data representative of Germany.
272. Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines.
作者: Alice Terrett.;Athena Chin.;Mihye Kwon.;Samuel Whittle.;Catherine Hill.
来源: BMC Rheumatol. 2025年9卷1期81页
Patients with autoimmune rheumatic diseases have high rates of surgical procedures including joint replacements despite the use of disease-modifying anti-rheumatic drugs (DMARDs). This scoping review compares clinical practice guideline recommendations for the perioperative management of DMARDs in such patients.
273. TNF-alpha inhibitors reduce the incidence of PsA in patients with psoriasis: a propensity score-matched cohort study.
作者: Stefano Piaserico.;Matteo Megna.;Federico Bardazzi.;Michela Magnano.;Giulia Giovanardi.;Giulia Odorici.;Clara De Simone.;Roberta Ramonda.;Andrea Conti.;Dennis McGonagle.
来源: Rheumatology (Oxford). 2025年64卷11期5803-5810页
Conflicting data exist on TNF inhibitors' (TNFi) role in preventing PsA in psoriasis. Using propensity score matching, we compared PsA incidence in severe psoriasis patients treated with TNFi vs narrow-band ultraviolet B (nbUVB) phototherapy over a decade of follow-up.
274. Exploring the role of gut microbiota in rheumatoid arthritis: the effects of diet and drug supplementation.
Rheumatoid Arthritis (RA) is a chronic autoimmune disease that mostly breaks out at the joints. It further causes bone erosion and decreased life quality due to severe pain. Current drugs are mainly focused on reducing pain, but unable to terminate the disease progression. This study aims to determine the effect of diet types (Western, Vegan and Mediterranean) on RA progression. Some dietary supplements and drug administration (Huayu-Qiangshen-Tongbi formula or Leflunomide plus Methotrexate) in a six-month-period were also simulated to elucidate their effects on gut microbiota growth and exchange metabolite fluxes. The computational analyses showed that Haemophilus parainfluenzae had the highest growth rate in the RA community with the Western diet. Enterococcus faecalis was the most notable bacterial species considering butyrate exchange rates without any dependency on the diet; however diet type became important for Clostridium celatum for acetate and formate exchanges. Focal interactions for RA communities signify Mediterranean diet had the most homogeneous exchange flux distribution. With iron and ornithine supplementation, Clostridium celatum outshined the rest of the bacteria in the RA community with the potential being an RA biomarker. The Mediterranean diet could be studied further for drug administration studies since the bacterial species under this diet exhibited different outputs. In the near future, by utilizing the potential of the gut microbiota to be altered with diet, it might be possible to manipulate the progression of RA.
275. Beliefs, preferences, and informational needs of patients with rheumatoid arthritis and concomitant cancer: a qualitative study.
作者: Juan I Ruiz.;Sheneze T Madramootoo.;Maria A Lopez-Olivo.;Namrata Singh.;Maria E Suarez-Almazor.
来源: BMC Rheumatol. 2025年9卷1期79页
Treatment of rheumatoid arthritis (RA) with biologic drugs in patients with cancer could potentially result in poor cancer outcomes. This study aimed to identify the beliefs, preferences, and informational needs of patients with RA and cancer regarding the harms, benefits, and uncertainties surrounding the use of RA therapy with respect to cancer.
276. Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study.
作者: Stylianos Georgiadis.;Daniela Di Giuseppe.;Almut Scherer.;Merete Lund Hetland.;Gareth T Jones.;Bente Glintborg.;Anne Gitte Loft.;Johan K Wallman.;Brigitte Michelsen.;Eirik Klami Kristianslund.;Ayten Yazici.;Merih Birlik.;Jakub Závada.;Michael J Nissen.;Adrian Ciurea.;Bjorn Gudbjornsson.;Olafur Palsson.;Ziga Rotar.;Matija Tomšič.;Heikki Relas.;Johanna Huhtakangas.;Ana Maria Rodrigues.;Maria José Santos.;Isabel Castrejon.;Federico Díaz-González.;Marleen van de Sande.;Pasoon Hellamand.;Lykke Midtbøll Ørnbjerg.
来源: BMC Rheumatol. 2025年9卷1期75页
To investigate a patient-level single imputation approach for patient reported outcomes (PROs) that express similar contents or associated PROs, where a PRO whose value is missing at a particular timepoint is substituted by another PRO whose value is available at the same timepoint.
277. Drug-induced hypersensitivity reaction presenting as systemic capillary leak-like syndrome with polyserositis: a case report.
作者: Ninh Xuan Nguyen.;Ngoc Tien Pham.;Huong Thi Thanh Le.;Quoc Viet Tran.;Hang Ngoc Thuy Tran.;An Thien Do.
来源: BMC Rheumatol. 2025年9卷1期74页
Systemic capillary leak syndrome (SCLS) is a rare disorder characterized by increased vascular permeability leading to third-spacing of fluids and protein. Drug-induced hypersensitivity reactions can mimic SCLS clinically and radiologically.
278. Examining how resistance training affects bone strength in older adults with rheumatic diseases: a systematic review.
Rheumatic diseases significantly impact global healthcare through disability, lost productivity, and reduced quality of life, making them an important focus for researchers. As physiological changes associated with aging decrease bone mineral density, rheumatic diseases further elevate fracture risk in older adults. Resistance training has been shown to counteract age-related declines through increases in muscle, strength, and bone mineral density, demonstrating its potential for mitigating bone mineral density loss. This systematic review examines the effectiveness of resistance training interventions in maintaining or improving bone mineral density in older adults with rheumatic diseases, an issue of relevance given impaired skeletal integrity linked to these diseases.
279. Diagnostic and therapeutic insights from a cohort of chronic recurrent multifocal osteomyelitis (CRMO) patients.
作者: Kosar Asna Ashari.;Mahdieh Mousavi.;Fatemeh Tahghighi Sharabian.;Raheleh Assari.;Seyyed Reza Raeeskarami.;Vahid Ziaee.
来源: BMC Rheumatol. 2025年9卷1期70页
Chronic recurrent multifocal osteomyelitis (CRMO) is a sporadic form of autoinflammatory bone disorders (ABDs) presenting with sterile chronic and/or recurrent and multiple sites of bone involvement. We aimed to describe our 10-year cohort of CRMO patients and analyze the characteristics and treatment approaches.
280. Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis.
作者: Jun Yan.;Hua Guo.;Lin-Xin Zhang.;Pei Chen.;Yong-Ku Du.;Juan Li.;Ya-Ya Gao.;Nan Ye.
来源: BMC Rheumatol. 2025年9卷1期69页
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint destruction and systemic inflammation, both of which significantly impair patients' quality of life. Mild cognitive impairment (MCI), a reversible precursor to dementia, is increasingly prevalent among elderly RA patients. Early identification of MCI in this population allows for timely interventions to slow cognitive decline.
|